Coca-Cola (KO) Q3 2025 earnings


Sina Schuldt | Picture Alliance | Getty Images

Coca-cola reported quarterly earnings and revenue that topped expectations, but the beverage giant said that demand for its drinks is still soft.

Here’s what the company reported compared with what Wall Street analysts surveyed by LSEG were expecting:

  • Earnings per share: 82 cents adjusted vs. 78 cents expected
  • Revenue: $12.41 billion adjusted vs. $12.39 billion expected

Coke reported third-quarter net income attributable to shareholders of $3.7 billion, or 86 cents per share, up from $2.85 billion, or 66 cents per share, a year earlier.

Excluding restructuring charges and other items, Coke earned 82 cents per share.

Net sales rose 5% to $12.46 billion. Coke’s organic revenue, which strips out acquisitions, divestitures and foreign currency, increased 6%.

Shares climbed nearly 3% in premarket trading.

The company’s unit case volume rose 1%, a reversal from last quarter’s decline. The metric excludes the impact of pricing and foreign currency to reflect demand.

But volume in both Latin America and North America, two key markets, was flat for the quarter. Coke executives have previously said that low-income consumers in the U.S. have been buying fewer of its products, although the company is trying to target them with affordable options.

Worldwide, Coke saw the largest volume growth from its water, sports, coffee and tea segment. Its bottled water and sports drinks both saw volume increase 3%, while coffee and tea reported volume growth of 2%. The company’s sparkling soft drinks volume was flat for the quarter, while its juice, value-added dairy and plant-based beverage segment reported that volume shrank 3%.

The company reiterated its full-year forecast. Coke is expecting comparable earnings per share to rise 3% and organic revenue to increase 5% to 6%.

Looking ahead to 2026, Coke is projecting a slight tailwind to both its revenue and comparable earnings from currency fluctuations. The company will provide a full forecast for the upcoming year in its fourth-quarter earnings report.


Related Posts

Alterra IOS CEO on the outperforming real estate sector hiding in plain sight

Industrial outdoor storage in Elgin, Illinois. Courtesy of Alterra IOS A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new…

McDonald’s (MCD) Q3 2025 earnings

The logo of McDonald’s is seen in Los Angeles, California. Lucy Nicholson | Reuters McDonald’s is expected to report its third-quarter earnings before the bell on Wednesday. Here’s what Wall…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Golden bat and ball for Richa Ghosh; Sourav Ganguly to give her hero’s welcome at Eden Gardens

  • By admin
  • November 6, 2025
  • 0 views
Golden bat and ball for Richa Ghosh; Sourav Ganguly to give her hero’s welcome at Eden Gardens

Farah Khan says she took up YouTube because she has 3 kids to send to college: ‘That’s bloody expensive!’

  • By admin
  • November 5, 2025
  • 1 views
Farah Khan says she took up YouTube because she has 3 kids to send to college: ‘That’s bloody expensive!’

Britannia Industries Q2 Results: Net profit rises 23% to ₹655 crore, beats estimates; revenue up 4% YoY

  • By admin
  • November 5, 2025
  • 4 views
Britannia Industries Q2 Results: Net profit rises 23% to ₹655 crore, beats estimates; revenue up 4% YoY

Alterra IOS CEO on the outperforming real estate sector hiding in plain sight

  • By admin
  • November 5, 2025
  • 3 views
Alterra IOS CEO on the outperforming real estate sector hiding in plain sight

Celebrity nutritionist Rujuta Diwekar shares ‘3 small lifestyle habits’ that can make a big impact on your health

  • By admin
  • November 5, 2025
  • 3 views
Celebrity nutritionist Rujuta Diwekar shares ‘3 small lifestyle habits’ that can make a big impact on your health

Artificial Intelligence Renders the FDA’s Current Drug Approval Process to be Obsolete – The Health Care Blog

  • By admin
  • November 5, 2025
  • 3 views
Artificial Intelligence Renders the FDA’s Current Drug Approval Process to be Obsolete – The Health Care Blog